Oxoid Agglutinating Sera, Salmonella 9-0 R30957301 Recall
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
FDA recall Class II
Ongoing
FDA lists this Class II recall for Oxoid Agglutinating Sera, Salmonella 9-0 R30957301. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1923-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Mar 25, 2026
- FDA report date
- Apr 29, 2026
- Quantity in commerce
- 117 US; 950 OUS
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Affected model & UDI checker
Search the exact identifiers published for Z-1923-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Oxoid Agglutinating Sera, Salmonella 9-0 R30957301 | Check source notice | 05056080500270 |
FDA code information
UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
Why was this product recalled?
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Remel Europe Ltd. take?
Firm began notifying consignees on March 25, 2026 via letters titled "Urgent: Medical Device Recall." Laboratory professionals are advised to review results and destroy any remaining inventory of affected lots. Affected lots should not be used for any clinical laboratory testing. Customers should complete and return the included acknowledgement form for replacement/credit to be processed. Notice should be passed on to all who need to be aware. Firm is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1923-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology